Sign Out
Immune system disorders: Hypersensitivity, anaphylactic shock.
Nervous system disorders: Paraesthesia, convulsions, dysgeusia, dyskinesia, dystonia, syncope, tremor, amnesia, memory impairment.
Hepatobiliary disorders: Hepatic function abnormal, transaminases increased, blood bilirubin increased, blood alkaline phosphate increased, gamma-glutamyl transferase increased, hepatitis.
Musculoskeletal and connective tissue disorders: Arthralgia.
Renal and urinary disorders: Dysuria, enuresis, urinary retention.
Blood and lymphatic disorders: Thrombocytopenia.
Psychiatric disorders: Agitation, aggression, confusion, depression, hallucination, insomnia, tics, suicidal ideation, nightmare.
Eye disorders: Accommodation disorder, blurred vision, oculogyration.
Gastro-intestinal disorders: Diarrhea.
Skin and subcutaneous tissue disorders: Pruritus, rash, urticaria, angioedema, fixed drug eruption, acute generalized exanthematous pustulosis (AGEP).
Metabolism and nutrition disorders: Increased appetite.
Ear and labyrinth disorders: Vertigo.
Investigations: Weight increased.
General disorders and administration site conditions: Asthenia, malaise, oedema.
Skin reactions occurring after discontinuation of Cetirizine: After discontinuation of Cetirizine, pruritus (intense itching) and/or urticaria have been reported.
View ADR Reporting Link
Continue with Google